DN
Therapeutic Areas
Insight Molecular Diagnostics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Blood-based transplant monitoring test | Post-transplant organ rejection monitoring | Commercial |
| Clinical assay for dd-cfDNA quantification | Kidney transplant surveillance | In Development |
| Research Use Only (RUO) dd-cfDNA test kit | Post-transplant organ rejection monitoring (research) | RUO |
| Genomic Copy Number Instability Test | Cancer therapeutic efficacy monitoring | In Development |
| 27-Gene Expression Laboratory Developed Test (LDT) | Immunotherapy response prediction | In Development |
| Research Use Only (RUO) 27-Gene Expression Assay Kit | Tumor microenvironment profiling (research) | RUO |
Leadership Team at Insight Molecular Diagnostics
ST
Steven Tahmooressi
Head of Transplant and Oncology Assay Marketing
JL
James Liu
Vice President of Accounting, Controller, Treasurer, Principal Accounting Officer
PH
Peter Hong
General Counsel
RA
Ryan Andrews
Vice President of Commercial
SO
Sandra O'Donald
Head of Business Operations
AJ
Andrea James
Head of Investor Relations & Strategy
Y(
Yuh-Min (Johnson) Chiang, PhD
Chief Technology Officer
PD
Prof. Dr. Ekkehard Schütz
Chief Science Officer